...cash. A survey in April of over 100 biotechs by BioCentury and investment management firm Sanford C. Bernstein...

...reaching that point, according to a survey last week by BioCentury and investment management firm Sanford C. Bernstein...

...Commissioner Stephen Hahn. The survey of 106 biotech companies by BioCentury and investment management firm Sanford C. Bernstein...

...at reduced valuations. A survey of 106 biotech companies by BioCentury and investment management firm Sanford C. Bernstein...

...Equity analyst Tim Anderson left the Sanford C. Bernstein research division of AllianceBernstein Holding L.P. (NYSE:AB) this month...

...have barely worked.” He elaborated on the failings of high deductibles in remarks to a Sanford C. Bernstein...

...million Price: $20 Shares after offering: 29.2 million Underwriters: BofA Merrill Lynch; Cowen; Piper Jaffray; Sanford C. Bernstein...

...million Price: $44.50 Shares after offering: 42.5 million Underwriters: Credit Suisse; Leerink Partners; Wells Fargo; Sanford C. Bernstein...

...2.5 million Price: $40 Shares after offering: 51.3 million Underwriters: Morgan Stanley; Credit Suisse; Cowen; Sanford C. Bernstein...

...Shares: 7 million Price: $23 Shares after offering: 23.5 million Underwriters: JPMorgan; Credit Suisse; Cowen; Sanford C. Bernstein...